[Procedures and methods of benefit assessments for medicines in Germany - a comment - letter no. 2].
Schünemann
Holger J
HJ
Kunz
Regina
R
Falck-Ytter
Yngve
Y
D019317:Evidence-Based Medicine / Q000592:standards*; D005858:Germany; D006801:Humans; D009313:National Health Programs / Q000191:economics / Q000592:standards*; D011787:Quality of Health Care; D012196:Review Literature as Topic